CapsicoHealth joins the prestigious CancerX
community dedicated to transforming cancer care. This community collaborates to develop and
implement solutions addressing key challenges in oncology. Through this partnership,
CapsicoHealth contributes to advancing innovation while benefiting from connections with
leading cancer centers, investors, and policy leaders committed to improving patient outcomes.
Learn More...
One of the complex challenges of modern healthcare is to redesign enterprises
using the next generation of tools, including AI and automation that can help
discover new drugs, enable faster trials, drive new insights from real-world
data, evaluate treatment options, study market access methods, and most
importantly drive patient outcomes.
Learn More...
In partnership with the ICARE4CVD-EU initiative on Precision Medicine and Personalized
Cardiovascular Care, CapsicoHealth is bringing the power of RWD, Gen-AI and Agentic
systems to analyze complex scientific documents and records to accelerate research in
the Pharmaceutical Industry. We presented at the prestigious
ESC Digital and AISummit Berlin, Germany, 2025.
Learn More...
The Problem: More than half of the new drugs or digital services launched by Life Sciences and Healthcare companies underperform in the markets due to poor patient identification for timely treatment options.
CapsicoHealth brings a market leading Gen-AI & LLM Platform and Agent Driven Workflows for Market Access, MSL, HEOR, Clinical Affairs stakeholders to get deep insight into targeted populations and treatment response.
Life Sciences and healthcare enterprises are challenged with analyzing billions of data points to generate insights, enable outcomes predictions and target populations for timely care.
Poor outcomes occur when patient pathways include suboptimal care and untimely treatments. Over 60% of patients do not see optimal treatment due to limited access.
Patient journeys are critical to driving insight into timely treatment and therapies, while ensuring outcomes improvement. The MSL co-pilot empowers medical science liasons, market access specialists and growth strategists on real-world insights on therapies.
